Work

Immunotherapy in hematologic malignancies: past, present, and future

Year: 2017

Type: article

Abstract: The field of immunotherapy in cancer treatments has been accelerating over recent years and has entered the forefront as a leading area of ongoing research and promising therapies that have changed the treatment landscape for a variety of solid malignancies. Prior to its designation as the Science Breakthrough of the Year in 2013, cancer immunotherapy was active in the treatment of hematologic malignancies. This review provides a broad overview of the past, present, and potential future of immunotherapy in hematologic malignancies.

Source: Journal of Hematology & Oncology

DOI: 10.1186/s13045-017-0453-8

Authors: Annie Im, Steven Z. Pavletic

Institutions: UPMC Hillman Cancer Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,990